{'fraction_non_alphanumeric': 0.018296169239565466, 'fraction_numerical': 0.02172670097198399, 'mean_word_length': 5.118881118881119, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Management of abnormal Pap smears in reproductive age group

Background: Human Papilloma Virus has garnered a great deal of attention in the gynaecologic literature over the past decade, primarily as it relates to abnormal pap smears. Cervical cancer is the leading cause of death in women in developing countries like India. It is preventable by regular screening by Pap smear and can be detected at pre-invasive stage. Thus, reducing the morbidity and mortality related with cervical cancers. Objective: This study aims at detecting the prevalence and current trends of various epithelial cell abnormalities (ECAs) in females of reproductive age group in a medical college hospital. Materials and Methods: This is a retrospective study conducted in a medical college hospital between August 2017 and July 2019. A total of 6,104 cases comprising 4,880 conventional and 1224 liquidbased cytology Pap smears were included in the study. Clinical data and history of the patients were retrieved. All cases were reported according to Bethesda system 2014. Results: Among 6,104 cases, 163 Pap smears were unsatisfactory, 5816 Pap smears were negative for intraepithelial lesion/malignancy, and 124 cases had ECA. Conclusion: The Pap smear has traditionally been the test we use to help screen patients for dysplasia. Over the past decade, additional tests which can detect oncogenic HPV have become commonplace and are now often performed in conjunction with pap smears. Large hospital-based studies are required for proper implementation of health services and for the selection of a feasible as well as sensitive screening test for early detection of cervical dysplasia which can be helpful in decreasing the burden of cervical cancer in our community.